论文部分内容阅读
目的 :探讨化疗泵的理想植入方法 ,总结其治疗恶性肿瘤生存率情况。方法 :对70例不能手术的恶性肿瘤患者行化疗泵植入术 ,并定期灌注化疗药物治疗。结果 :埋泵成功率98.6 %(69/70)。肺癌患者临床症状改善 ,病灶缩小 ,其中2例行ΙΙ期手术切除。24例肝癌和12例直结肠癌病例中 ,分别有21例(87.5 %)和8例(66.7 %)显示病灶缩小。结论 :经皮植入化疗泵治疗恶性肿瘤具有诸多优点 ,疗效显著可以提高带瘤患者生存率。
Objective: To investigate the ideal implantation method of chemotherapy pump and summarize its treatment of malignant tumor survival rate. Methods: 70 cases of inoperable malignant tumor patients underwent chemotherapy pump implantation, and regular infusion of chemotherapy drugs. Results: Buried pump success rate was 98.6% (69/70). The clinical symptoms of lung cancer patients improved, the lesion was reduced, of which 2 cases underwent ΙΙ surgical resection. Twenty-one (87.5%) and eight (66.7%) of the 24 HCC cases and 12 of the 12 cases of colon cancer patients showed lessened lesions. Conclusion: Percutaneous implantation of chemotherapy pump for the treatment of malignant tumors has many advantages and significant curative effect can improve the survival rate of patients with tumor.